FDA: Nearly 65K adverse reactions recorded in 43.9M COVID doses, most not serious | ABS-CBN
ADVERTISEMENT

Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
FDA: Nearly 65K adverse reactions recorded in 43.9M COVID doses, most not serious
FDA: Nearly 65K adverse reactions recorded in 43.9M COVID doses, most not serious
Davinci Maru,
ABS-CBN News
Published Oct 08, 2021 02:55 PM PHT
|
Updated Oct 08, 2021 03:17 PM PHT

MANILA— The Philippines has recorded nearly 65,000 adverse reactions to COVID-19 vaccination, majority considered non-serious, the Food and Drug Administration said Friday.
MANILA— The Philippines has recorded nearly 65,000 adverse reactions to COVID-19 vaccination, majority considered non-serious, the Food and Drug Administration said Friday.
This represents only 0.15 percent of the 43.9 million COVID-19 vaccine doses administered in the country, FDA director general Eric Domingo said.
This represents only 0.15 percent of the 43.9 million COVID-19 vaccine doses administered in the country, FDA director general Eric Domingo said.
Of the total, 62,294 reactions were suspected to be non-serious events, according to Sept. 26 data of the FDA's adverse event following immunization (AEFI) reporting.
Of the total, 62,294 reactions were suspected to be non-serious events, according to Sept. 26 data of the FDA's adverse event following immunization (AEFI) reporting.
Meanwhile, some 2,597 or 0.0006 percent were suspected serious adverse reactions associated with COVID-19 vaccines, data further showed.
Meanwhile, some 2,597 or 0.0006 percent were suspected serious adverse reactions associated with COVID-19 vaccines, data further showed.
ADVERTISEMENT
"This is within acceptable level and, in fact, mataas ang reporting rates ng ating AEFI sa ating community (we have high reporting rates of AEFI in our community). Sa WHO, kinilala tayo ang Pilipinas (The World Health Organization recognized the Philippines) as having the highest reporting rate ng AEFI dito sa (here in) Asia," he said.
"This is within acceptable level and, in fact, mataas ang reporting rates ng ating AEFI sa ating community (we have high reporting rates of AEFI in our community). Sa WHO, kinilala tayo ang Pilipinas (The World Health Organization recognized the Philippines) as having the highest reporting rate ng AEFI dito sa (here in) Asia," he said.
The FDA had said that adverse reactions experienced after vaccination were considered serious when it resulted in any of the following criteria:
The FDA had said that adverse reactions experienced after vaccination were considered serious when it resulted in any of the following criteria:
- In-patient hospitalization/prolongation of existing hospitalization
- Significant disability/incapacity
- Life-threatening condition (e.g. anaphylaxis) and death
- Birth defect or congenital malformations
- Considered to be a medically important event
- In-patient hospitalization/prolongation of existing hospitalization
- Significant disability/incapacity
- Life-threatening condition (e.g. anaphylaxis) and death
- Birth defect or congenital malformations
- Considered to be a medically important event
Pain in the injection site, fever, fatigue, headache and dizziness were among the most common non-serious adverse reactions to the anti-virus jab.
Pain in the injection site, fever, fatigue, headache and dizziness were among the most common non-serious adverse reactions to the anti-virus jab.
As of Sept. 26, here are adverse events recorded per vaccine brand:
As of Sept. 26, here are adverse events recorded per vaccine brand:
- Sinovac - 25,849 (0.10 percent) out of 24,813,589 doses administered
- AstraZeneca - 30,998 (0.44 percent) out of of 6,942,940 doses administered
- Pfizer - 3,059 (0.07 percent) out of 4,505,757 doses administered
- Janssen - 2,899 (0.08 percent) out of 3,585,355 doses administered
- Moderna - 1,356 (0.04 percent) out of 3,336,741 doses administered
- Sputnik V - 693 (0.18 percent) out of 387,818 doses administered
- Sinopharm - 37 (0.01 percent) out of 361,686 doses administered
- Sinovac - 25,849 (0.10 percent) out of 24,813,589 doses administered
- AstraZeneca - 30,998 (0.44 percent) out of of 6,942,940 doses administered
- Pfizer - 3,059 (0.07 percent) out of 4,505,757 doses administered
- Janssen - 2,899 (0.08 percent) out of 3,585,355 doses administered
- Moderna - 1,356 (0.04 percent) out of 3,336,741 doses administered
- Sputnik V - 693 (0.18 percent) out of 387,818 doses administered
- Sinopharm - 37 (0.01 percent) out of 361,686 doses administered
Video courtesy of the DOH
Read More:
FDA
Food and Drug Administration
Eric Domingo
adverse events
adverse reaction
COVID-19
COVID19
coronavirus
COVID-19 vaccination
COVID-19 vaccines
ADVERTISEMENT
ADVERTISEMENT